EXPLORING THE CLINICAL AND BIOCHEMICAL LANDSCAPE OF TYPE 2 DIABETES MELLITUS IN MALE PATIENTS

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder primarily characterized by insulin resistance and impaired glucose metabolism. The disease affects men and women differently, with male patients exhibiting distinct clinical presentations, risk factors, and biochemical profiles. This paper explores the clinical and biochemical aspects of T2DM in male patients, with a focus on the role of testosterone, fat distribution, and cardiovascular risks in disease manifestation. Understanding these gender-specific factors is crucial for developing targeted treatment approaches, improving disease outcomes, and reducing complications in male patients.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-13
DOI
https://doi.org/10.5281/zenodo.14134183
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EXPLORING THE CLINICAL AND BIOCHEMICAL LANDSCAPE OF TYPE 2 DIABETES MELLITUS IN MALE PATIENTS

Zenodo (CERN European Organization for Nuclear Research)
Diabetes, Cardiovascular Risks, and Lipoproteins
article

EXPLORING THE CLINICAL AND BIOCHEMICAL LANDSCAPE OF TYPE 2 DIABETES MELLITUS IN MALE PATIENTS

article en

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder primarily characterized by insulin resistance and impaired glucose metabolism. The disease affects men and women differently, with male patients exhibiting distinct clinical presentations, risk factors, and biochemical profiles. This paper explores the clinical and biochemical aspects of T2DM in male patients, with a focus on the role of testosterone, fat distribution, and cardiovascular risks in disease manifestation. Understanding these gender-specific factors is crucial for developing targeted treatment approaches, improving disease outcomes, and reducing complications in male patients.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 54%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EXPLORING THE CLINICAL AND BIOCHEMICAL LANDSCAPE OF TYPE 2 DIABETES MELLITUS IN MALE PATIENTS · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS